331 related articles for article (PubMed ID: 28656201)
41. [CK19 can be used to predict the early recurrence and prognosis of HBV-related hepatocellular carcinoma patients with low AFP serum concentration after R0 radical hepatectomy].
Wang ZS; Wu LQ; Yi X; Geng C; Li YJ; Yao RY; Hu WY; Han B
Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):753-8. PubMed ID: 23291069
[TBL] [Abstract][Full Text] [Related]
42. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
43. miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Yen CS; Su ZR; Lee YP; Liu IT; Yen CJ
World J Gastroenterol; 2016 Jun; 22(22):5183-92. PubMed ID: 27298561
[TBL] [Abstract][Full Text] [Related]
44. High expression of TACC2 in hepatocellular carcinoma is associated with poor prognosis.
Shakya M; Zhou A; Dai D; Zhong Q; Zhou Z; Zhang Y; Li X; Bholee AK; Chen M
Cancer Biomark; 2018; 22(4):611-619. PubMed ID: 29843208
[TBL] [Abstract][Full Text] [Related]
45. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma.
Huang LL; Zhang Y; Zhang JX; He LJ; Lai YR; Liao YJ; Tian XP; Deng HX; Liang YJ; Kung HF; Xie D; Zhu SL
Tumour Biol; 2015 Jun; 36(6):4405-15. PubMed ID: 25596704
[TBL] [Abstract][Full Text] [Related]
47. CD163 and CD206 expression does not correlate with tolerance and cytokine production in LPS-tolerant human monocytes.
Alves-Januzzi AB; Brunialti MKC; Salomao R
Cytometry B Clin Cytom; 2017 May; 92(3):192-199. PubMed ID: 26352275
[TBL] [Abstract][Full Text] [Related]
48. Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas.
Hsiao YW; Chiu LT; Chen CH; Shih WL; Lu TP
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31434354
[TBL] [Abstract][Full Text] [Related]
49. Prognostic role of macrophages and mast cells in the microenvironment of hepatocellular carcinoma after resection.
Ali E; Červenková L; Pálek R; Ambrozkiewicz F; Hošek P; Daum O; Liška V; Hemminki K; Trailin A
BMC Cancer; 2024 Jan; 24(1):142. PubMed ID: 38287290
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of APOBEC3F in tumor tissues is potentially predictive for poor recurrence-free survival from HBV-related hepatocellular carcinoma.
Yang Z; Zhuang L; Yu Y; Zhou W; Lu Y; Xu Q; Tang B; Chen X
Discov Med; 2015 Dec; 20(112):349-56. PubMed ID: 26760979
[TBL] [Abstract][Full Text] [Related]
51. Human U Three Protein 14a Expression is Increased in Hepatocellular Carcinoma and Associated with Poor Prognosis.
Zhang JY; Xu D; Liu ZZ; Li Y; Wang LJ; Xing BC
Chin Med J (Engl); 2017 Feb; 130(4):470-476. PubMed ID: 28218222
[TBL] [Abstract][Full Text] [Related]
52. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
53. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.
Ramzan M; Sturm N; Decaens T; Bioulac-Sage P; Bancel B; Merle P; Tran Van Nhieu J; Slama R; Letoublon C; Zarski JP; Jouvin-Marche E; Marche PN; Leroy V
Liver Int; 2016 Mar; 36(3):434-44. PubMed ID: 26215124
[TBL] [Abstract][Full Text] [Related]
54. Extracellular vesicle-associated soluble CD163 and CD206 in patients with acute and chronic inflammatory liver disease.
Nielsen MC; Andersen MN; Grønbæk H; Damgaard Sandahl T; Møller HJ
Scand J Gastroenterol; 2020 May; 55(5):588-596. PubMed ID: 32393080
[No Abstract] [Full Text] [Related]
55. CXCR2-CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma.
Li L; Xu L; Yan J; Zhen ZJ; Ji Y; Liu CQ; Lau WY; Zheng L; Xu J
J Exp Clin Cancer Res; 2015 Oct; 34():129. PubMed ID: 26503598
[TBL] [Abstract][Full Text] [Related]
56. Hypermethylation of ACP1, BMP4, and TSPYL5 in Hepatocellular Carcinoma and Their Potential Clinical Significance.
Qiu X; Hu B; Huang Y; Deng Y; Wang X; Zheng F
Dig Dis Sci; 2016 Jan; 61(1):149-57. PubMed ID: 26386860
[TBL] [Abstract][Full Text] [Related]
57. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
[TBL] [Abstract][Full Text] [Related]
58. Activation of IL6/IGFIR confers poor prognosis of HBV-related hepatocellular carcinoma through induction of OCT4/NANOG expression.
Chang TS; Wu YC; Chi CC; Su WC; Chang PJ; Lee KF; Tung TH; Wang J; Liu JJ; Tung SY; Kuo LM; Ho HN; Ling TY; Huang YH
Clin Cancer Res; 2015 Jan; 21(1):201-10. PubMed ID: 25564572
[TBL] [Abstract][Full Text] [Related]
59. Transferrin receptor 1 overexpression is associated with tumour de-differentiation and acts as a potential prognostic indicator of hepatocellular carcinoma.
Adachi M; Kai K; Yamaji K; Ide T; Noshiro H; Kawaguchi A; Aishima S
Histopathology; 2019 Jul; 75(1):63-73. PubMed ID: 30811632
[TBL] [Abstract][Full Text] [Related]
60. Microlocalization and clinical significance of stabilin-1
Wang B; Huang H; Yang M; Yang W; Liu Z; Hou W; Zeng H; He Z; Lin T; Huang J
World J Urol; 2020 Mar; 38(3):709-716. PubMed ID: 31302753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]